Abstract
Incidence of venous thromboembolism (VTE) in children is rapidly rising. Frequent use of central venous lines (CVLs) in children with a variety of disease processes has contributed to increased incidence of VTE. In addition, increased detection of VTE has been possible due to the availability of sensitive imaging studies such as Color Duplex/Doppler ultrasound, lineogram and venogram. Heightened awareness of congenital prethrombotic disorders may help identify children at higher risk of thrombosis. Anticoagulation with heparin, low molecular weight heparin (LMWH) and oral anticoagulant such as warfarin are used for the treatment of VTE. Thrombolytic therapy may be indicated in some cases. Clinical presentation, management and pathogenesis including role of congenital prethrombotic disorders in pediatric VTE are discussed.
Similar content being viewed by others
References
Rosendaal FR. Thrombosis in the young: Epidemiology and risk factors. A focus on venous thrombosis.Thromb-Haemos 1997; 78: 1–6.
Marzinotto V, Adams Met al. Catheter related thrombosis in childre receiving home TPN: Incidence, diagnosis, management.Thromb Haemost 1993; 69: 1079.
Andrew M, Marzinotto Vet al. A cross-sectional study of catheter-related thrombosis in children receiving total parentral nutrition at home.J Pediatr 1995; 126: 358.
Shen, L, Dahlback B. Factor V and Protein C in degradation of Factor VIIIa.J Biol Chem 1994;; 269: 18735–18738.
Andrew M. The hemostatic system in the infant. In: Nathan and Oski (eds).Hematology of Infancy and Childhood 4th edn Vol. 1. W.B. Saunders Company, Philadelphia, PA, 1993: 115–153.
Karparkin M, Mannuccio-Mannucci P, Bhogal Met al. Low protein C in the neonatal period.Br. J Haematol 1986; 62: 137–142.
Schwarz HP, Mutean W, Watzke H,et al. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates.Blood 1988; 71: 562–565.
Bauer KA. Rare coagulation factor abnormalities. In: Nathan DG and Orkin SH (eds.)Hematology of Infancy and Childhood. Philadelphia, W.B. Saunders, Co, 1998, pp. 1960–1675.
Koster T, Rosendaal FRet al. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study.Lancet 1993; 342: 1503.
Dahlback B. Resistance to Activated Protein C as Risk Factor for Thrombosis: Molecular Mechanisms, Laboratory Investigation, and Clinical Management.Seminars in Hematology 1997; 34: 217–234.
Sutor AH and Uhl M. Diagnosis of thromboembolic diseases during infancy and childhood.Seminars in Thrombosis and Hemostasis 1997; 23: 237–246.
Andrew M, David M, Adams M.et al. Venous Thromboembolic Complications (VTE) in Children: First Analyses of the Canadian Registry of VTE.Blood 1994; 83: 1251–1257.
David M, Andrew M. Venous thromboembolism complication in children. A critical review of literature.J Pediatr 1993; 123: 337.
Bounameaux H, de Moerloose P, Perrier A.et al. Plasma measurement ofD-dimer as diagnostic aid in suspected venous thromboembolism: an overview.Thrombosis and Haemostasis 1994; 71: 1–6.
Manco-Johnson MJ. Disorders of hemostasis in childhood: risk factors for venous thromboembolism.Thromb Haemost 1997; 78: 710–714.
Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children.Chest 1995; 108: 506S-522S.
Andrew M, Michelson AD, Bovill E.et al. Guidelines for antithrombotic therapy in pediatric patients.J Pediatr 1998; 132: 575–588.
Andrew M, Marzinotto V.et al. Heparin therapy in pediatric patients: A prospective cohort study.Pediatr Res, 1994; 35: 78.
Sutor AH, Massicotte P, Leaker M, Heparin therapy in pediatric patients.Seminars in Thrombosis and Hemostasis 1997; 23: 303–319.
Andrew M, Montgomery RR. Acquired disorders of hemostasis. In: Nathan and Oski (eds.)Hematology of Infancy and Childhood, 5th edn. Vol. 2. W.B. Saunders Company Philadelphia, P.A. 1998: 1677–1717.
Hull R, Rastob G, Rosenbloom D. Heparin for 5 days as compared with 10 days in initial treatment of proximal venous thrombosis.N Engl J Med 1990; 322: 1260.
Schuster J. Pathology of osteopathy following heparin therapy.J Pediatr Surg 1969; 20: 410.
Potter C. Heparin induced thrombocytopenia in a child.J Pediatri 1992; 121: 135–138.
Andrew M, de Veber G. Pediatric thromboembolism and Stroke Protocols. Hamilton-London B.D. Decker, Inc, 1997, pp 1–29.
Andrew M, Marzinotto V, Brooker LA.et al. Oral anticoagulation therapy in pediatric patients: A prospective study.Thromb Haemost 1994; 71: 265–269.
Leaker M, Massicotte MP, Brooker LAet al. Thrombolytic therapy in pediatric patients: A comprehensive reveiw of the literature.Thromb-Haemost 1996; 76: 132–134.
Zenz W, Arlt F, Sodia Set al. Intracerebral hemorrhage during fibrinolytic therapy in children: A review of the literature of the last thirty years.Seminars in Thrombosis and Hemostasis 1997; 23: 321–332.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gera, R., Kulkarni, R. Venous thromboembolism. Indian J Pediatr 66, 163–169 (1999). https://doi.org/10.1007/BF02761196
Issue Date:
DOI: https://doi.org/10.1007/BF02761196